A Phase 2 Pilot Study to Assess ASP7147 in Patients With Diarrhea Predominant Irritable Bowel Syndrome (IBS-D)

Completed · Phase 2 · Has a placebo group

Conditions studied: Diarrhea Predominant Irritable Bowel Syndrome

In brief

This trial will evaluate the effect of ASP7147 on daily abdominal pain due to IBS-D during 4 weeks of treatment. It will also evaluate safety and tolerability in patients with IBS-D over the 4-week treatment period.

Key facts

Study ID
NCT01896583
Run by
Seldar Pharma, Inc.
People needed
64
Starts
2013-11-01
Expected to finish
2014-07-01
Last updated by the study team
2019-06-06

Who can join

Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.